Hyperglycemia
This medicine may increase blood sugar.
Medicine information ONBREZ BREEZHALER 300mcg capsules with inhalation powder
- Product code:
- W64464002
- Quantity:
- 30
- Indicated for:
- chronic obstructive pulmonary disease
- Route of administration:
- inhalation
- Substance:
- indacaterol (beta-2 adrenergic agonist)
- ATC
- R03AC18 — Respiratory system | Adrenergics, inhalants | Selective beta-2-adrenoreceptor agonists
Indacaterol is a bronchodilator used to treat chronic obstructive pulmonary disease (COPD). It belongs to the class of long-acting beta-2 adrenergic agonists and helps relax the muscles of the airways, making breathing easier.
The medication is administered via inhalation, usually once daily, as directed by a doctor.
Side effects may include cough, headache, dizziness, or throat irritation. In rare cases, severe allergic reactions or palpitations may occur.
Patients should strictly follow the usage instructions and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.
The medication is administered via inhalation, usually once daily, as directed by a doctor.
Side effects may include cough, headache, dizziness, or throat irritation. In rare cases, severe allergic reactions or palpitations may occur.
Patients should strictly follow the usage instructions and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.
General data about ONBREZ BREEZHALER 300mcg
- Substance:
- indacaterol
- Date of latest medicines list:
- 01-10-2026
- Product code:
- W64464002
- Strength:
- 300mcg
- Pharmaceutical form:
- capsules with inhalation powder
- Quantity:
- 30
- Product type:
- Original
- Price:
- 137.30 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Strengths available for indacaterol
- 150mcg
- 300mcg
Combinations with other substances
Official documents
The correspondence between the document and the displayed text is unconfirmed.
- Source institution
- EMA
- Document language
- English
- Source record: first published
- 05/01/2010
- Source record: last updated
- 18/11/2025
Warnings:
Cardiac risk / QT prolongation / arrhythmias
This medicine may increase the risk of heart rhythm disturbances.
Reimbursement lists for ONBREZ BREEZHALER 300mcg Europharm
B - Sublist B with 50% discount from the reference price
- Price
- 137.30 RON
- Copayment
- 68.65 RON
- Patient payment
- 68.65 RON